Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(6): 211-216


Human platelet lysate-derived exosomes are superior to the lysate at increasing collagen deposition in a rat model of intrinsic aging

Ervina Rosmarwati, Endra Yustin Ellistasari, Arie Kusumawardani, Indah Julianto, Suci Widhiati, Novan Adi Setyawan, Frieda Yanuar.




Abstract
Cited by 0 Articles

The decreased production of collagen in intrinsic aging skin is most likely due to the downregulation of connective tissue growth factor (GF) which is thought to be a regulator of collagen expression. Human platelet lysate (HPL) contains many nutrients needed for cell growth and proliferation. The GFs are contained not right in liquid lysate but in exosomes. Our study demonstrated the superiority of Exo-HPL compared to HPL in decreasing matrix metalloproteinase (MMP)-1 level and increasing collagen deposition in intrinsic aging rat models (IRMs) induced by injection of D-galactose. The highest deposition of collagen at 40× magnification is found in IRM + Exo-HPL treatment group (38.40%) which is close to collagen deposition in the young rats group (42.90%). At 100× magnification the study demonstrated that there was higher collagen deposition in IRM + Exo-HPL treatment group (39.94%) than in IRM + HPL treatment group (34.53%) which was close to the young rat group’s collagen deposition (43.26%). This study found a significant difference in MMP-1 level and collagen deposition among all groups. Both Exo-HPL and HPL treatment groups decreased MMP-1 levels and increased collagen deposition compared to IRM group. Exo-HPL treatment group was more effective in decreasing MMP-1 level and increasing collagen deposition compared to HPL treatment group and IRM group significantly.

Key words: collagen, D-Gal, Exo-HPL, HPL, Intrinsic Aging, MMP-1






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.